Press Releases

October 21, 2011 | Press Release
Washington, D.C. - Members of the Bicameral Repeal CLASS Working Group sent a letter October 20 to Secretary of Health and Human Services (HHS) Kathleen Sebelius reiterating earlier questions about her knowledge of the flawed financial structure of the controversial Community Living Assistance Services and Supports (CLASS) program, which was created in Presid
October 20, 2011 | Press Release
WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) are urging Energy Secretary Steven Chu to make DOE officials available for transcribed interviews under oath as part of the committee's ongoing Solyndra investigation.
October 19, 2011 | Press Release
WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) wrote to White House Counsel Kathryn Ruemmler renewing their request for all internal White House communications related to Solyndra.
October 17, 2011 | Press Release
WASHINGTON, D.C. - Reps. Greg Walden (R-OR) and Lee Terry (R-NE), the chairman and vice chairman of the House Energy and Commerce Communications and Technology Subcommittee, today welcomed news of an agreement reached by the Federal Communications Commission and the wireless industry to avert "bill shock" among wireless users. The agreement calls for carriers to alert consumers before they reach their wireless plan limits, giving them advance warning before they accrue additional charges.
October 17, 2011 | Press Release
WASHINGTON, DC - Energy and Commerce Committee Chairman Fred Upton (R-MI) and Oversight and Investigations Subcommittee Chairman Cliff Stearns (R-FL) responded to the recent letter from White House Counsel Kathryn Ruemmler that the White House would not provide internal White House communications related to Solyndra.
October 14, 2011 | Press Release
WASHINGTON, DC - The United States for decades has led the global medical device industry, providing life-saving and life-improving devices to patients and employing more than two million people in device-related jobs.  However, the Food and Drug Administration's unpredictable, inconsistent, and non-transparent handling of the review process has threatened our nation's medical device leadership, hurting patients, American jobs, and innovation.

Pages